The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Korean shorthairs among favorite cat breeds as more people choose to adopt pets

  • 3

    REVIEW'The ODD Of LOVE' concert: Taeyeon shows why she is among K-pop's top vocalists

  • 5

    Korea beats Nigeria to advance to semifinals at FIFA U-20 World Cup

  • 7

    Agency launched to offer exclusive support for overseas Koreans

  • 9

    INTERVIEWKorean food undergoes renaissance in US

  • 11

    Stats agency to use Naver's AI chatbot to offer tailored data for firms

  • 13

    Asiana Airlines pilots union to initiate mass flight delays

  • 15

    Memorial event to be held for fallen Thai soldiers of Korean War

  • 17

    'The Second Husband' co-stars to tie knot, expecting child in real life

  • 19

    Toyota launches Crown CUV in Korea to boost sales

  • 2

    Uhm Jung-hwa enjoys second heyday with JTBC series 'Doctor Cha'

  • 4

    Tom Cruise to visit Korea to promote new film

  • 6

    3 EXO members file antitrust complaint against SM Entertainment

  • 8

    ANALYSISS. Korean economy feared to follow in Japan's footsteps

  • 10

    Korea's export dependency on China dips below 20%

  • 12

    Retail investors bet on wrong horse despite KOSPI rally

  • 14

    Retailers use recycled, biodegradable plastic to attract eco-conscious consumers

  • 16

    7 Vietnamese nabbed for suspected drug use at club

  • 18

    Korea pushes digital technology exports to Middle East, Japan, ASEAN

  • 20

    4 Chinese, 4 Russian military planes enter Korea's air defense zone without notice

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
Wed, June 7, 2023 | 08:36
Tech
INTERVIEWKorean drugmakers 'virtualizing' COVID-19 studies
Posted : 2020-09-14 15:27
Updated : 2020-09-14 20:17
Park Jae-hyuk
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
Medidata co-founder and co-CEO Glen De Vries, and the cover of his recently published book, 'The Patient Equation' / Courtesy of Medidata
Medidata co-founder and co-CEO Glen De Vries, and the cover of his recently published book, "The Patient Equation" / Courtesy of Medidata

By Park Jae-hyuk

Korean pharmaceutical companies began to test their COVID-19 treatment and vaccine candidates in a "virtualized" format, through their partnerships with Medidata, a Dassault Systemes subsidiary which offers a cloud platform for the entire clinical trial process.

Glen De Vries, co-founder and co-CEO of Medidata, told The Korea Times in a recent interview that his company has had many conversations with Korean drugmakers and most of them have developed into partnerships.

"Korean biopharmaceutical companies are utilizing our solutions within their ongoing COVID-19 clinical trials," he said.

His company's platform is already being used in the United States for the development of mRNA-1273, Moderna's COVID-19 vaccine candidate. The U.S. drugmaker's clinical trial using the Medidata platform was one of the largest clinical trials ever to be conducted in a virtualized format.

"The response to the impact of COVID-19 on clinical studies has been the increased use of and reliance on solutions like trial virtualization," De Vries said.

"Our technology solutions enable virtualized trials that can keep current trials moving forward and initiating new trials, while decreasing the potential spread of infectious diseases like COVID-19 using remote monitoring ― further prioritizing the health and safety of patients."

The co-founder said his company has talked with Korean biopharmaceutical companies not only about COVID-19 vaccine development, but also for other therapeutic areas, because of their growing interest in remote monitoring.

"We are continuously forming partnerships with major Korean biotechnology and pharmaceutical companies, such as Hanmi Pharmaceutical, Celltrion, Medytox, Boryung Pharmaceutical and SCM Lifescience," he said.

"Hanmi and Medytox are using our risk-based monitoring solution to extend their clinical trial practices beyond Korea by adopting global standards."

He considered the pandemic has led global authorities and regulatory agencies worldwide to demonstrate a general openness to the integration of technology with clinical trials.

"Now that we are able to utilize technology that we didn't have years ago, we can consider this as an opportunity to place patients at the center of how we develop research tools, and enhance interaction and engagement," he said.

"Allowing for remote consent, monitoring and tele-visits will help medical research to advance, even in the face of a pandemic."

In this regard, he published a book recently titled, "The Patient Equation," to introduce the new paradigm of new medicine development.

"The term Patient Equation means that there is a mathematical framework to make sure that we can repeatedly and reliably identify those therapies that are going to reach people at the right time in the right amount to create the best possible medical outcome," he said.

"I see further opportunities of patient equations by looking at a much broader set of data in a much more sophisticated way. I don't think my thoughts on patient equation is restricted to mere certain parts of the globe, but everywhere, including South Korea."


Emailpjh@koreatimes.co.kr Article ListMore articles by this reporter
 
wooribank
Top 10 Stories
1Asiana Airlines pilots union to initiate mass flight delays Asiana Airlines pilots union to initiate mass flight delays
2Korean food's global popularity leads to copycat products in China, Japan Korean food's global popularity leads to copycat products in China, Japan
3Presidential office's plan to revamp TV viewing fees causes stir Presidential office's plan to revamp TV viewing fees causes stir
4International Yoga Day to celebrate well-being of body, mind International Yoga Day to celebrate well-being of body, mind
5Incheon announces plans to become hub for overseas Koreans Incheon announces plans to become hub for overseas Koreans
6ROK-US alliance is now nuclear-based: President Yoon ROK-US alliance is now nuclear-based: President Yoon
7Hyundai Motor, IKEA join hands to promote sustainable outdoor activities Hyundai Motor, IKEA join hands to promote sustainable outdoor activities
8Egyptian national arrested for possession of cannabis cookie Egyptian national arrested for possession of cannabis cookie
9Samsung family takes out stock loans to pay inheritance tax Samsung family takes out stock loans to pay inheritance tax
10Ex-top trade negotiator to serve as US think tank standing senior fellow Ex-top trade negotiator to serve as US think tank standing senior fellow
Top 5 Entertainment News
1[REVIEW] 'The ODD Of LOVE' concert: Taeyeon shows why she is among K-pop's top vocalists REVIEW'The ODD Of LOVE' concert: Taeyeon shows why she is among K-pop's top vocalists
2Baritone Kim Tae-han wins Queen Elisabeth Competition Baritone Kim Tae-han wins Queen Elisabeth Competition
3Busan Film Festival accepts director Huh Moon-yung's resignation Busan Film Festival accepts director Huh Moon-yung's resignation
4[INTERVIEW] 'One Day Off' star Lee Na-young, director on creating subtle, feel-good series INTERVIEW'One Day Off' star Lee Na-young, director on creating subtle, feel-good series
5'HyeMiLeeYeChaePa' producer Lee Tae-kyung hopeful of second season 'HyeMiLeeYeChaePa' producer Lee Tae-kyung hopeful of second season
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group